Accreditation and Designation User Manual - OECI
Accreditation and Designation User Manual - OECI
Accreditation and Designation User Manual - OECI
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Performing the peer review<br />
Executor: <strong>OECI</strong> audit team<br />
Performing the peer review according to the peer review agenda (doc 16).<br />
During the peer review <strong>and</strong> in the evenings, the auditors will work on scoring the st<strong>and</strong>ards (Yes, Mostly,<br />
Partially, No)for the report <strong>and</strong> drawing the preliminary conclusions, strengths <strong>and</strong> opportunities.<br />
<strong>Designation</strong> checklist during the peer review visit:<br />
− Ask the list on scientific publications including an overview of the authors’ papers in the hospital (First,<br />
second <strong>and</strong> last author should be clarified)<br />
− Overview is enough, when doubt on the correction of the numbers check impact factor <strong>and</strong> especially in<br />
the impact factor >10<br />
− Ask on site at different wards at least two times the number of beds<br />
• Cross check, yes or no<br />
− Ask on site at the day care the number of beds/chairs (total)<br />
• Cross check, yes or no<br />
− Ask in two different interviews the number of physicians from different specialties<br />
− Ask on site the number of active clinical trials<br />
• Cross check, yes or no<br />
− Check the facilities the availability of the radiotherapy, medical oncology <strong>and</strong> surgical oncology<br />
• Check availability, 3 times yes or no<br />
In case the preliminary designation is between a Clinical Cancer Centre <strong>and</strong> a Comprehensive Cancer Centre,<br />
the audit team will have to additionally focus, during the peer review visit, on the following criteria:<br />
− A highly innovative character <strong>and</strong> multidisciplinary approach using the potential of basic, translational <strong>and</strong><br />
clinical research <strong>and</strong> clinical facilities <strong>and</strong> activities, organised in a sufficiently identifiable entity [Short<br />
description]<br />
− A direct provision of an extensive variety of cancer care tailored to the individual patient’s needs <strong>and</strong><br />
directed towards learning <strong>and</strong> improving the professional, organisational <strong>and</strong> relational quality of care<br />
[Short description]<br />
− Broad activities in the area of prevention, education, <strong>and</strong> external dissemination of knowledge <strong>and</strong><br />
innovation. In order to accentuate the differences with other cancer institutes [Short description]<br />
− The level of infrastructure, expertise <strong>and</strong> innovation in the field of oncology research [Short description]<br />
− Maintenance of an extensive network including all aspects of oncology treatment <strong>and</strong> research [Short<br />
description]<br />
Writing notes during the auditors’ peer review<br />
The notes of the interviews, tours <strong>and</strong> presentation will be processed into the e-tool by the auditors during<br />
<strong>and</strong> after the peer review.<br />
The auditors have one week after the peer review visit to process the notes <strong>and</strong> to provide the descriptions<br />
to support the designation type.<br />
The auditors have a personal username <strong>and</strong> password to enter the e-tool <strong>and</strong> to go to the peer review report<br />
of the institute. Auditors can process their notes in the e-tool at the same time.<br />
The answers need to provide evidence/proof for the scores given to the st<strong>and</strong>ard.<br />
The report needs to be:<br />
− Recognisable,<br />
− Concrete,<br />
− Compact,<br />
− Separate minor <strong>and</strong> major points,<br />
− Strength <strong>and</strong> weaknesses from appendices in text,<br />
− Objective statements,<br />
− Examples,<br />
− Reasonable arguments for subjective statements,<br />
− Unanimously agreed by the auditors team.<br />
Owner: <strong>OECI</strong> Organisation of European Cancer Institutes<br />
Status: Revised - 24 th January 2011 - A&D Working Group<br />
Approved by: <strong>OECI</strong> <strong>Accreditation</strong> <strong>and</strong> <strong>Designation</strong> Board<br />
Chapter 5 Ten steps A&D process in detail<br />
Page 18 of 28<br />
Version 16 February 2011